2. Natural Products
  3. Plants
  4. Scrophulariaceae
  5. Bacopa monnieri (Linn.) Wettst.

Bacopa monnieri (Linn.) Wettst.

Bacopa monnieri (Linn.) Wettst. (18):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-N6016
    Bacopaside II 382146-66-9 98.86%
    Bacopaside II, an extract from the medicinal herb Bacopa monnieri. Bacopaside II is the inhibitor for AQP1 that exhibits anti-angiogenesis activity. Bacopaside II exhibits cytotoxicity and induces apoptosis in cancer cells.
    Bacopaside II
  • HY-N5064
    Bacoside A3 157408-08-7 99.85%
    Bacoside A3 is a triterpenoid saponin isolated from Bacopa monnieri. Bacoside A3 has neuroprotective activity, downregulating β-amyloid-induced inflammatory responses and inhibiting neuronal apoptosis. Bacoside A3 can be used in the study of Alzheimer's disease.
    Bacoside A3
  • HY-N5140
    Bacopaside X 94443-88-6 99.64%
    Bacopaside X is found in Bacopa monnieri, and shows a binding affinity toward the D1 receptor.
    Bacopaside X
  • HY-N6015
    Bacopasaponin C 178064-13-6 99.76%
    Bacopasaponin C is an orally active natural glycoside. Bacopasaponin C can be isolated from Bacopa monniera. Bacopasaponin C inhibits Verapamil (HY-14275)-stimulated P-gp ATPase activity with an IC50 of 57.83 μg/mL. Bacopasaponin C has antitumor activity against sarcomas. Bacopasaponin C has antiparasitic activity against Leishmania donovani.
    Bacopasaponin C
  • HY-N4246
    Bacopaside I 382148-47-2 99.20%
    Bacopaside I is an orally active aquaporin AQP1 inhibitor and PKC modulator with neuroprotective and anticancer activities. Bacopaside I specifically blocks the water channel and cGMP-gated ion channel activities of AQP1 without affecting AQP4, thereby inhibiting the migration of colon cancer cells expressing AQP1. Bacopaside I activates the Akt pathway by interacting with PI3K, specifically inhibits MAO-A, effectively alleviates neuron necrosis and apoptosis induced by oxygen-glucose deprivation, reduces oxidative stress, and regulates the surface expression of neuroreceptors. When combined with Bacopaside II (HY-N6016), Bacopaside I significantly reduces the viability, proliferation and invasion ability of breast cancer cells, and binds to the pregnane X receptor (PXR). Bacopaside I is applicable to the research of colon cancer, breast cancer, vascular dementia, cerebral ischemia and other related diseases.
    Bacopaside I
  • HY-N18388
    Bacopaside VI
    Bacopaside VI is a Bacopaside. Bacopaside VI can be isolated from Bacopa monnieri.
    Bacopaside VI
  • HY-N1989
    Bacoside A 11028-00-5
    Bacoside A is an orally active, blood-brain barrier-permeable triterpenoid saponin that modulates the activities of ATPases, AChE, CaMK2A and iNOS. Derived from Bacopa monniera. Bacoside A exerts significant antioxidant, anti-inflammatory and anti-apoptotic effects by maintaining ion balance, scavenging reactive oxygen species, stabilizing cell membranes, and regulating the expression of NF-κB and apoptosis-related proteins. Bacoside A counteracts morphine-induced reductions in Na+/K+-ATPase, Ca2+-ATPase and Mg2+-ATPase activities, increases mitochondrial membrane potential, and decreases intracellular reactive oxygen species levels. Bacoside A specifically binds to calcium/calmodulin-dependent protein kinase IIA to trigger endoplasmic reticulum calcium release. Bacoside A exhibits non-apoptotic cytotoxicity against glioblastoma cells while protecting normal nerve cells from stress-induced damage. Bacoside A is applicable to the research of Parkinson's disease and glioblastoma multiforme.
    Bacoside A
  • HY-N6016R
    Bacopaside II (Standard) 382146-66-9
    Bacopaside II (Standard) is the analytical standard of Bacopaside II. This product is intended for research and analytical applications. Bacopaside II, an extract from the medicinal herb Bacopa monnieri, blocks the Aquaporin-1 (AQP1) water channel and impairs migration of cells that express AQP1. Bacopaside II induces cell cycle arrest and apoptosis.
    Bacopaside II (Standard)
  • HY-N5064R
    Bacoside A3 (Standard) 157408-08-7
    Bacoside A3 (Standard) is the analytical standard of Bacoside A3. This product is intended for research and analytical applications. Bacoside A3, a triterpenoid saponin, is one of the major active constituents in Bacopa monnieri. Bacoside A3 has neuroprotective activity.
    Bacoside A3 (Standard)
  • HY-N4246R
    Bacopaside I (Standard) 382148-47-2
    Bacopaside I (Standard) is the analytical standard of Bacopaside I. This product is intended for research and analytical applications. Bacopaside I is an orally active aquaporin AQP1 inhibitor and PKC modulator with neuroprotective and anticancer activities. Bacopaside I specifically blocks the water channel and cGMP-gated ion channel activities of AQP1 without affecting AQP4, thereby inhibiting the migration of colon cancer cells expressing AQP1. Bacopaside I activates the Akt pathway by interacting with PI3K, specifically inhibits MAO-A, effectively alleviates neuron necrosis and apoptosis induced by oxygen-glucose deprivation, reduces oxidative stress, and regulates the surface expression of neuroreceptors. When combined with Bacopaside II (HY-N6016), Bacopaside I significantly reduces the viability, proliferation and invasion ability of breast cancer cells, and binds to the pregnane X receptor (PXR). Bacopaside I is applicable to the research of colon cancer, breast cancer, vascular dementia, cerebral ischemia and other related diseases.
    Bacopaside I (Standard)
  • HY-N6015R
    Bacopasaponin C (Standard) 178064-13-6
    Bacopasaponin C (Standard) is the analytical standard of Bacopasaponin C (HY-N6015). This product is intended for research and analytical applications. Bacopasaponin C is an orally active natural glycoside. Bacopasaponin C can be isolated from Bacopa monniera. Bacopasaponin C inhibits Verapamil (HY-14275)-stimulated P-gp ATPase activity with an IC50 of 57.83 μg/mL. Bacopasaponin C has antitumor activity against sarcomas. Bacopasaponin C has antiparasitic activity against Leishmania donovani.
    Bacopasaponin C (Standard)
  • HY-N9373
    Bacoside A2 58798-95-1
    Bacoside A2 is a triterpenoid saponin.
    Bacoside A2
  • HY-N8222
    Bacopaside N1 871706-74-0
    Bacopaside N1 is a diglycosidic saponin.
    Bacopaside N1
  • HY-N8216
    Bacopaside IV 155545-03-2
    Bacopaside IV is a saponin.
    Bacopaside IV
  • HY-N7966
    Bacopaside N2 871706-75-1
    Bacopaside N2 is a diglycosidic saponin.
    Bacopaside N2
  • HY-N4295
    Bacopaside V 620592-16-7 99.37%
    Bacopaside V is a bioactive triterpenoid glycoside of Bacopa monniera, a herb having confirmed nervine tonic activity.
    Bacopaside V
  • HY-N2444
    Bacosine 198014-94-7
    Bacosine is a Triterpenoids product that can be isolated from the herbs of Bacopa monnieri.
    Bacosine
  • HY-N5140R
    Bacopaside X (Standard) 94443-88-6
    Bacopaside X (Standard) is the analytical standard of Bacopaside X. This product is intended for research and analytical applications. Bacopaside X is found in Bacopa monnieri, and shows a binding affinity toward the D1 receptor.
    Bacopaside X (Standard)